ALDX
Price
$4.83
Change
+$0.06 (+1.26%)
Updated
Jan 17, 04:59 PM (EDT)
Capitalization
288.22M
47 days until earnings call
ATAI
Price
$1.46
Change
+$0.07 (+5.04%)
Updated
Jan 17, 04:59 PM (EDT)
Capitalization
244.99M
68 days until earnings call
Ad is loading...

ALDX vs ATAI

Header iconALDX vs ATAI Comparison
Open Charts ALDX vs ATAIBanner chart's image
Aldeyra Therapeutics
Price$4.83
Change+$0.06 (+1.26%)
Volume$911
Capitalization288.22M
ATAI Life Sciences
Price$1.46
Change+$0.07 (+5.04%)
Volume$12.71K
Capitalization244.99M
ALDX vs ATAI Comparison Chart
Loading...
ALDX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ATAI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ALDX vs. ATAI commentary
Jan 18, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ALDX is a Hold and ATAI is a Hold.

Ad is loading...
COMPARISON
Comparison
Jan 18, 2025
Stock price -- (ALDX: $4.78 vs. ATAI: $1.39)
Brand notoriety: ALDX and ATAI are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ALDX: 57% vs. ATAI: 37%
Market capitalization -- ALDX: $288.22M vs. ATAI: $244.99M
ALDX [@Biotechnology] is valued at $288.22M. ATAI’s [@Biotechnology] market capitalization is $244.99M. The market cap for tickers in the [@Biotechnology] industry ranges from $368.92B to $0. The average market capitalization across the [@Biotechnology] industry is $2.37B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ALDX’s FA Score shows that 0 FA rating(s) are green whileATAI’s FA Score has 1 green FA rating(s).

  • ALDX’s FA Score: 0 green, 5 red.
  • ATAI’s FA Score: 1 green, 4 red.
According to our system of comparison, both ALDX and ATAI are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ALDX’s TA Score shows that 4 TA indicator(s) are bullish while ATAI’s TA Score has 5 bullish TA indicator(s).

  • ALDX’s TA Score: 4 bullish, 5 bearish.
  • ATAI’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, ATAI is a better buy in the short-term than ALDX.

Price Growth

ALDX (@Biotechnology) experienced а -6.46% price change this week, while ATAI (@Biotechnology) price change was -14.20% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -1.05%. For the same industry, the average monthly price growth was +3.04%, and the average quarterly price growth was -1.59%.

Reported Earning Dates

ALDX is expected to report earnings on May 01, 2025.

ATAI is expected to report earnings on May 20, 2025.

Industries' Descriptions

@Biotechnology (-1.05% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ALDX($288M) has a higher market cap than ATAI($245M). ATAI YTD gains are higher at: 4.511 vs. ALDX (-4.208). ALDX has higher annual earnings (EBITDA): -42.57M vs. ATAI (-124.33M). ALDX has more cash in the bank: 113M vs. ATAI (85.9M). ALDX has less debt than ATAI: ALDX (15.6M) vs ATAI (23.8M). ATAI has higher revenues than ALDX: ATAI (331K) vs ALDX (0).
ALDXATAIALDX / ATAI
Capitalization288M245M118%
EBITDA-42.57M-124.33M34%
Gain YTD-4.2084.511-93%
P/E RatioN/AN/A-
Revenue0331K-
Total Cash113M85.9M132%
Total Debt15.6M23.8M66%
FUNDAMENTALS RATINGS
ALDX vs ATAI: Fundamental Ratings
ALDX
ATAI
OUTLOOK RATING
1..100
7075
VALUATION
overvalued / fair valued / undervalued
1..100
42
Fair valued
78
Overvalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9798
PRICE GROWTH RATING
1..100
4347
P/E GROWTH RATING
1..100
10016
SEASONALITY SCORE
1..100
11n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

ALDX's Valuation (42) in the Biotechnology industry is somewhat better than the same rating for ATAI (78) in the Miscellaneous Commercial Services industry. This means that ALDX’s stock grew somewhat faster than ATAI’s over the last 12 months.

ALDX's Profit vs Risk Rating (100) in the Biotechnology industry is in the same range as ATAI (100) in the Miscellaneous Commercial Services industry. This means that ALDX’s stock grew similarly to ATAI’s over the last 12 months.

ALDX's SMR Rating (97) in the Biotechnology industry is in the same range as ATAI (98) in the Miscellaneous Commercial Services industry. This means that ALDX’s stock grew similarly to ATAI’s over the last 12 months.

ALDX's Price Growth Rating (43) in the Biotechnology industry is in the same range as ATAI (47) in the Miscellaneous Commercial Services industry. This means that ALDX’s stock grew similarly to ATAI’s over the last 12 months.

ATAI's P/E Growth Rating (16) in the Miscellaneous Commercial Services industry is significantly better than the same rating for ALDX (100) in the Biotechnology industry. This means that ATAI’s stock grew significantly faster than ALDX’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ALDXATAI
RSI
ODDS (%)
N/A
Bearish Trend 4 days ago
81%
Stochastic
ODDS (%)
Bullish Trend 4 days ago
78%
Bullish Trend 4 days ago
82%
Momentum
ODDS (%)
Bearish Trend 4 days ago
82%
Bullish Trend 4 days ago
84%
MACD
ODDS (%)
Bearish Trend 4 days ago
87%
Bullish Trend 4 days ago
81%
TrendWeek
ODDS (%)
Bearish Trend 4 days ago
83%
Bearish Trend 4 days ago
86%
TrendMonth
ODDS (%)
Bearish Trend 4 days ago
79%
Bearish Trend 4 days ago
85%
Advances
ODDS (%)
Bullish Trend 15 days ago
83%
Bullish Trend 12 days ago
79%
Declines
ODDS (%)
Bearish Trend 4 days ago
80%
Bearish Trend 4 days ago
86%
BollingerBands
ODDS (%)
Bearish Trend 4 days ago
88%
Bearish Trend 4 days ago
80%
Aroon
ODDS (%)
Bullish Trend 4 days ago
90%
Bearish Trend 4 days ago
88%
View a ticker or compare two or three
Ad is loading...
ALDX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ATAI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
SPY591.64-1.14
-0.19%
SPDR® S&P 500® ETF Trust
BTC.X99756.910000-747.585940
-0.74%
Bitcoin cryptocurrency
GME27.72-0.24
-0.86%
GameStop Corp
TSLA413.82-14.40
-3.36%
Tesla
AAPL228.26-9.61
-4.04%
Apple

ALDX and

Correlation & Price change

A.I.dvisor indicates that over the last year, ALDX has been loosely correlated with GSGTF. These tickers have moved in lockstep 56% of the time. This A.I.-generated data suggests there is some statistical probability that if ALDX jumps, then GSGTF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ALDX
1D Price
Change %
ALDX100%
-4.88%
GSGTF - ALDX
56%
Loosely correlated
N/A
ATAI - ALDX
43%
Loosely correlated
-3.47%
FOLD - ALDX
43%
Loosely correlated
+0.97%
ABSI - ALDX
43%
Loosely correlated
-2.10%
ROIV - ALDX
41%
Loosely correlated
-1.63%
More

ATAI and

Correlation & Price change

A.I.dvisor indicates that over the last year, ATAI has been loosely correlated with NTLA. These tickers have moved in lockstep 46% of the time. This A.I.-generated data suggests there is some statistical probability that if ATAI jumps, then NTLA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ATAI
1D Price
Change %
ATAI100%
-3.47%
NTLA - ATAI
46%
Loosely correlated
-2.99%
FATE - ATAI
45%
Loosely correlated
-5.30%
MNMD - ATAI
45%
Loosely correlated
-3.70%
ABCL - ATAI
45%
Loosely correlated
-0.68%
VTGN - ATAI
44%
Loosely correlated
-1.68%
More